Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truqap or Vistusertib + Paclitaxel in Gastric Cancer
NCT02449655Phase 2Terminated
- Sponsor
- Samsung Medical Center
- Start
- Feb 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capivasertib, vistusertib in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started Feb 2015; status: terminated.
02
Drugs
capivasertibvistusertib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT02449655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449655.